According to Abeona Therapeutics 's latest financial reports the company's total liabilities are $49.17 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $37.45 M | 0.63% |
2021-12-31 | $37.21 M | -23.49% |
2020-12-31 | $48.64 M | 8.22% |
2019-12-31 | $44.95 M | 11.39% |
2018-12-31 | $40.35 M | 365.55% |
2017-12-31 | $8.66 M | -27.53% |
2016-12-31 | $11.96 M | -3.03% |
2015-12-31 | $12.33 M | 4.83% |
2014-12-31 | $11.76 M | -23.56% |
2013-12-31 | $15.39 M | -18.15% |
2012-12-31 | $18.8 M | -12.08% |
2011-12-31 | $21.39 M | -27.65% |
2010-12-31 | $29.56 M | 3.48% |
2009-12-31 | $28.57 M | 86.05% |
2008-12-31 | $15.35 M | 81.35% |
2007-12-31 | $8.46 M | -48.09% |
2006-12-31 | $16.31 M | 42.47% |
2005-12-31 | $11.45 M | -35.5% |
2004-12-31 | $17.75 M | 0.65% |
2003-12-31 | $17.63 M | -7.17% |
2002-12-31 | $18.99 M | 15.78% |
2001-12-31 | $16.4 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Merck MRK | $69.04 B | 140,293.69% | ๐บ๐ธ USA |
Taro Pharmaceutical TARO | $0.38 B | 681.04% | ๐ฎ๐ฑ Israel |